Alpha Cognition Inc. Files 8-K on Director Changes and Compensation
Ticker: ACOG · Form: 8-K · Filed: Oct 24, 2024 · CIK: 1655923
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, filing-update
TL;DR
Alpha Cognition Inc. 8-K: Director changes, compensation details, and financial exhibits filed Oct 24.
AI Summary
Alpha Cognition Inc. filed an 8-K on October 24, 2024, reporting on the departure of directors or certain officers, the election of directors, and compensatory arrangements. The filing also includes financial statements and exhibits. The company, formerly known as Neurodyn Cognition Inc., is incorporated in British Columbia and has its principal executive offices in Vancouver.
Why It Matters
This filing provides crucial updates on the company's leadership and financial reporting, which can impact investor confidence and strategic direction.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with compensatory arrangements, can signal internal shifts that may affect the company's future performance.
Key Players & Entities
- Alpha Cognition Inc. (company) — Registrant
- Neurodyn Cognition Inc. (company) — Former Company Name
- October 21, 2024 (date) — Earliest event reported
- October 24, 2024 (date) — Filing Date
FAQ
What specific director or officer positions were affected by the changes reported in the 8-K?
The filing indicates "Departure of Directors or Certain Officers" and "Election of Directors" and "Appointment of Certain Officers" as items reported, but does not specify names or positions within this excerpt.
What are the details of the compensatory arrangements for certain officers mentioned in the filing?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not provided in this excerpt.
What financial statements and exhibits are included with this 8-K filing?
The filing states that "Financial Statements and Exhibits" are included, but the specific list or content of these documents is not detailed in this excerpt.
When was Alpha Cognition Inc. formerly known as Neurodyn Cognition Inc. and when did the name change occur?
The company was formerly known as Neurodyn Cognition Inc., and the date of the name change was October 16, 2015.
What is the principal executive office address for Alpha Cognition Inc.?
The principal executive offices are located at 1200 - 750 West Pender Street, Vancouver, British Columbia, V6C 2T8.
Filing Stats: 774 words · 3 min read · ~3 pages · Grade level 11.8 · Accepted 2024-10-24 06:29:49
Key Financial Figures
- $275,000 — . Mr. Du will receive a base salary of $275,000 per year and will be eligible for a yea
Filing Documents
- ea0218494-8k_alpha.htm (8-K) — 26KB
- 0001213900-24-090112.txt ( ) — 191KB
- acogf-20241021.xsd (EX-101.SCH) — 3KB
- acogf-20241021_lab.xml (EX-101.LAB) — 33KB
- acogf-20241021_pre.xml (EX-101.PRE) — 22KB
- ea0218494-8k_alpha_htm.xml (XML) — 3KB
02 Departure of Directors
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Departure of Mr. Jay Yoo On October 21, 2024, Mr. Jay Yoo tendered his resignation as interim Principal Accounting and Financial Officer of Alpha Cognition Inc. (the "Company"), effective October 21, 2024. Appointment of Mr. Henry Du On October 21, 2024, the Company appointed Mr. Henry Du, age 46, to act as the Company's Vice President of Finance and Accounting and interim Chief Financial Officer effective October 21, 2024. Mr. Du brings to the Company over 20 years of experience in corporate accounting and finance, with a strong business background in the life science industry. From November 2022 to October 2024, Mr. Du was Sr. Vice President of Accounting and Administration at Amplify Surgical, a medical device company focused on developing innovative endoscopic surgical techniques and spinal implant technologies, where he led the finance and accounting functions, as well as administrative roles including human resources, payroll, compliance, corporate legal, and investor relations. During his tenure there, he was instrumental in helping the company achieve consistent positive EBITDA and profitability, along with doubling average daily operating liquidity. From September 2021 to November 2022, Mr. Du was also VP of Finance and Senior Corporate Controller at HUYABIO International, a leader in globalizing Chinese pharmaceutical innovation, where he established the commercial accounting policy for the company's product launch in Japan. Prior to HUYABIO, Mr. Du served in leadership roles at Eledon Pharmaceuticals (formerly Novus Therapeutics), a publicly traded clinical-stage biopharmaceutical company from May 2018 to September 2021, United Auto Credit from August 2017 to May 2018, and at Avanir Pharmaceuticals from March 2010 to August 2017. Mr. Du will receive a base salary of $275,000 per year and will
01 Financial Statements, Pro Forma
Item 9.01 Financial Statements, Pro Forma Financial Information and Exhibits. (d) Exhibits: Exhibit Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ALPHA COGNITION INC. By: /s/ Michael McFadden Michael McFadden Chief Executive Officer Dated: October 24, 2024 2